Microvascular response to shock wave application in striated skin muscle by Calcagni, M et al.
University of Zurich





Microvascular response to shock wave application in striated
skin muscle
Calcagni, M; Chen, F; Högger, D C; Lindenblatt, N; Keel, M; Giovanoli, P; Contaldo,
C
Calcagni, M; Chen, F; Högger, D C; Lindenblatt, N; Keel, M; Giovanoli, P; Contaldo, C (2010). Microvascular
response to shock wave application in striated skin muscle. Journal of Surgical Research:Epub ahead of print.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Journal of Surgical Research 2010, :Epub ahead of print.
Calcagni, M; Chen, F; Högger, D C; Lindenblatt, N; Keel, M; Giovanoli, P; Contaldo, C (2010). Microvascular
response to shock wave application in striated skin muscle. Journal of Surgical Research:Epub ahead of print.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Journal of Surgical Research 2010, :Epub ahead of print.
Microvascular response to shock wave application in striated
skin muscle
Abstract
Background: This study aims to quantify by intravital microscopy the microhemodynamic response after
extracorporeal shock wave application (ESWA) to the physiologic microcirculation of the mouse dorsal
skinfold chamber.
Materials and Methods: ESWA was carried out using an electrohydraulic shock wave source. Two
different shock wave doses of 500 and 1000 pulses at an energy flux rate of 0.08 mJ/mm2 and a
frequency of 4 Hz were compared with sham-operated animals. Microcirculatory analyses were
performed at baseline (BL) and during a 3 d observation period after ESWA. The expression of
caspase-3 (casp-3), proliferating cell nuclear antibody (PCNA), von Willebrand factor (vWF), and
endothelial nitric oxide synthase (eNOS) were analyzed semiquantitatively by immunohistochemistry.
Results: ESWA provoked a significant and persistent increase of functional capillary density (FCD)
throughout the observation period, reaching a maximum (140% ± 5% of BL, P < 0.05 versus sham) after
1 d when animals were treated with 1000 pulses. ESWA induced a slight increase of leukocyte rolling
(not, vert, similar2- to not, vert, similar3.5-fold, P < 0.05) and leukocyte adherence (not, vert,
similar1.5- to not, vert, similar2-fold, P < 0.05) to the endothelial lining of postcapillary venules. One
day following ESWA, we observed enhanced expression of casp-3 (not, vert, similar3- to not, vert,
similar4-fold), PCNA (not, vert, similar9- to not, vert, similar14-fold), vWF (not, vert, similar11- to not,
vert, similar14-fold), and eNOS (not, vert, similar3-fold), all P < 0.05.
Conclusion: This study shows that ESWA provokes a favorable persistent increase of patent capillaries,
however accompanied by a transient and slight inflammatory response but also by dose-dependant
apoptotic cell death. Our data suggest that ESWA might represent a noninvasive biomechanical tool to
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Background. This study aims to quantify by intravi-
tal microscopy the microhemodynamic response after
extracorporeal shock wave application (ESWA) to the
physiologic microcirculation of the mouse dorsal skin-
fold chamber.
Materials andMethods. ESWAwascarriedoutusing
an electrohydraulic shock wave source. Two different
shock wave doses of 500 and 1000 pulses at an energy
flux rate of 0.08 mJ/mm2 and a frequency of 4 Hz were
compared with sham-operated animals. Microcircula-
tory analyseswere performed at baseline (BL) anddur-
ing a 3 d observation period after ESWA. The
expression of caspase-3 (casp-3), proliferating cell nu-
clear antibody (PCNA), von Willebrand factor (vWF),
andendothelial nitric oxide synthase (eNOS)were ana-
lyzed semiquantitatively by immunohistochemistry.
Results. ESWAprovoked a significant and persistent
increase of functional capillary density (FCD) through-
out the observation period, reaching a maximum (140%
±5%ofBL,P< 0.05 versus sham) after 1 dwhenanimals
weretreatedwith1000pulses.ESWAinducedaslight in-
crease of leukocyte rolling (w2- tow3.5-fold, P< 0.05)
and leukocyte adherence (w1.5- to w2-fold, P < 0.05)
to the endothelial lining of postcapillary venules. One
day following ESWA,we observed enhanced expression
of casp-3 (w3- tow4-fold), PCNA (w9- tow14-fold), vWF
(w11- tow14-fold), and eNOS (w3-fold), all P< 0.05.
Conclusion. This study shows that ESWA provokes
a favorable persistent increase of patent capillaries,
however accompanied by a transient and slight in-
flammatory response but also by dose-dependant apo-
ptotic cell death. Our data suggest that ESWA might
represent a noninvasive biomechanical tool to treat
critically perfused and endangered tissues, butU1 To whom correspondence and reprint requests should be ad-
dressed at Department of Surgery, Division of Plastic and Reconstruc-
tive Surgery, University Hospital Zurich, CH-8091 Zurich,
Switzerland.claudio. E-mail: contaldo@usz.ch.
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(PCNA); von Willebrand factor (vWF); endothelial








Extracorporeal shock wave application (ESWA) is in-
creasingly investigated for the management of acute
and chronic inflammatory pathologies of muscle, nerve,
and skin [1–3]. Shock waves are usually electrohy-
draulically induced biphasic transient pressure
changes characterized by a fast positive and a following
slower negative wave. After reaching a tissue boundary,
the acoustic energy is transformed into mechanical en-
ergy, whereby its biological effect is directly propor-
tional to the difference in impedance of the two
adjacent media. One of the indirect biological effects is
the cavitation phenomenon (CP). CP is thought to occur
during the second phase of a shock wave, when the neg-
ative pressure induces the formation of ultrastructural
vesicles, which by collapsing cause a multidirectional
asymmetrical fluid stream within the tissue [4]. The
successful treatment of bony non-union when using
ESWA was thought to be related to CP by causing micro-
fractures and stimulating healing [5]. However, molec-
ular biological investigations in rat femurs exposed to
ESW demonstrated the stimulation of bone-marrow
stromal growth and its differentiation towards osteo-
progenitors through the induction of tumor growth fac-
tor (TGF-b1) [6]. Similar findings in a segmental bone
defect model indicated a predominant chemotactic and0022-4804/10 $36.00
 2010 Elsevier Inc. All rights reserved.












































































































































mitogen role of vascular endothelial growth factor
(VEGF-A) in the recruitment and differentiation of mes-
enchymal stem cells after ESWA [7]. Enhanced cellular
proliferation and regeneration by proliferating cell
nuclear antibody (PCNA) and insulin-like growth factor
(IGF-I) were demonstrated after ESWA of rat Achilles
tendons [8]. Furthermore ESWA has been shown to ex-
ert a significant synergistic growth inhibitory effect on
tumour cells when applied in combination with chemo-
therapeutic agents [9, 10], which was explained by
CP-induced permeabilization of cellular membranes
and intercellular connections [11, 12]. Recent investiga-
tions revealed decreased leukocytic infiltration and sup-
pression of tumour necrosis factora (TNF-a) in critically
perfused random skin flaps after ESWA [13]. Only few
studies report the biological effect of ESWA on the circu-
latory system. Increased local perfusion after low dose
ESWA in patients suffering from advanced ischemic
limb disease coincided with the clinical improvement
of the patient’s pain-free walking distance [14]. Simi-
larly, ESWA improved regional myocardial blood flow
in a porcine model of chronic cardiac ischemia as mea-
sured by coloured microspheres [15, 16]. This effect
could be reproduced in humans with end-stage coronary
artery disease, whereby increased myocardial perfusion
persisted for at least 12 mo [17]. In another study of car-
diac ESWA, enhanced coronary angiogenesis was asso-
ciated with reduced angina pectoris in patients with
severe coronary artery disease, whereby no adverse ef-
fects were noted [18]. Accordingly, improved local perfu-
sion was suggested after ESWA-associated reduction of
necrosis using an epigastric skin flap model and a dorsal
skin random flap model, respectively [13, 19–21]. The
exposition of human umbilical vascular endothelial cells
(HUVECs) to low dose ESWA revealed a significant up-
regulation of VEGF m-RNA protein, indicating a direct
vascular effect [22]. Induction of neovascularisation by
ESWA could histologically be confirmed in Achilles ten-
dons of dogs and rabbits [23, 24]. In another study using
adductor muscles in rats, stroma cell-derived factor 1
(SDF-1) together with VEGF were increased following
ESWA, indicating the up-regulation of chemoattrac-
tants targeting circulating endothelial progenitor cells
to promote angio- and vasculogenesis [24]. To date,
there is no study exploring the in vivo effect of ESWA
on the microcirculation. The present study investigates
the microvascular response to ESWA in the mouse








Experiments were performed according to the guidelines of the







the Federal Veterinary Office of Zurich. A total of 33 mice (C57BL/6
J; 12–24 wk; 2–26 g body weight (BW); Harlan, Switzerland) were in-
cluded in the study. The animals were housed in single cages at
a room temperature (RT) of 22C and at a relative humidity of
60%–65% with a 12 h/12 h light-dark cycle. The animals were allowed
free access to tap water and standard laboratory chow.
Experimental Model
The dorsal skinfold chamber in mice was used for intravital
microscopy as previously described [25, 26]. Briefly, mice were anes-
thetized intraperitoneally with a mixture of 90 mg/kg BW ketamine
hydrochloride (Ketavet; QParke Davis; Freiburg, Germany) and 25
mg/kg BW xylazine hydrochloride (Rompun; Bayer, Leverkusen,
Germany), and two symmetric titanium frames were implanted to
sandwich the extended double layer of the skin. One layer was
removed in a 15 mm diameter circular area. The remaining layer
consisting of epidermis, subcutaneous tissue, and striated skin mus-
cle was covered with a glass coverslip, incorporated in one of the
titanium frames. Animals tolerated the chamber well and showed
no signs of discomfort or changes in sleeping and feeding habits. A
recovery period of 3 d was allowed before the experiment was
started.
Extracorporeal Shock Wave Application (ESWA)
The anesthetized animals were placed in left lateral position.
ESWA to the chamber tissue was carried out using an electrohydrau-
lic shock wave source (dermaPACE; Sanuwave, Switzerland). An
ultrasound transmission gel (Parker Laboratories Inc Q., NJ) was ap-
plied as contact medium to the applicator, which was gently placed di-
rectly on the dorsal skinfold chamber tissue after removing the cover
glass. ESWA was performed with a dose of 500 or 1000 pulses, with an
energy flux rate of 0.08 mJ/mm2, and at a frequency of 4 Hz. Sham-
prepared skinfold chambers were treated identically during 2 min,
however no ESWA was performed.
Intravital Fluorescence Microscopy
For in vivo microscopic analysis of the microcirculation, the anes-
thetized mice were placed in left lateral position on a Plexiglas stage.
Microhemodynamic measurements were performed using an epi-
illumination intravital microscope (Leica DM/LM; Leica Microsys-
tems, Wetzlar, Germany) attached to a blue (450–490/ > 520 nm),
a green (530–560/ > 580 nm), and an ultraviolet (330–390/ > 430
nm excitation/emission wavelength) filter system. Microscopic images
were displayed on a television screen (Trinitron PVM-20N5E; Sony,Q
UK), and recorded on video (50 Hz; Panasonic AG-7350-SVHS; Tokyo,
Japan) for subsequent off-line analysis. The preparation was observed
visually with a water immersion objective320 with a numerical aper-
ture of 0.50, which resulted in total optical magnification of 3800 on
the video monitor. Animals received a tail vein injection of 0.05 mL
fluoresceinisothiocyanate (FITC)-dextran (MW 150,000; 50 mg/mL
saline), (Sigma-Aldrich, Buchs, Switzerland) for vascular contrast en-
hancement, and 0.05 mL rhodamine 6 G (0.1 mg/mL saline), (Sigma-
Aldrich, Buchs, Switzerland) for leukocyte staining in vivo. This al-
lowed for quantitative analysis of microvascular perfusion and leuko-
cyte-endothelial cell interaction using long distance objectives
(magnification: 34, numerical aperture: 0.16; 310, 0.30; 320, 0.32;
Zeiss Q). The microvessels were classified according to physiological
and anatomical features into conduit arterioles, capillaries and small
collecting venules.
Quantitative Microcirculation Analysis
The chamber was scanned for random selection of distinct observa-






Baseline date of microcirculation and leukocyte-en-
dothelial cell interaction
Control gw 500 gw 1000
Arterioles
Diameter [mm] 29.5 6 5.6 30.8 6 2.7 28.1 6 3.7
RBC velocity [mm/s] 1.14 6 0.32 1.13 6 0.12 1.05 6 0.12
Blood flow [nl/s] 49.5 6 10.3 46.9 6 5.46 47.8 6 11.7
Venules
Diameter [mm] 22.8 6 4.8 23.4 6 1.7 24.8 6 6.4
RBC velocity [mm/s] 0.34 6 0.06 0.31 6 0.03 0.33 6 0.09
Blood flow [nl/s] 19.1 6 2.7 16.9 6 2.7 17.0 6 3.5




187 6 13 189 6 10 171 6 13
Diameter [mm] 4.50 6 0.52 4.76 6 0.38 4.73 6 0.38
RBC velocity [mm/s] 0.33 6 0.15 0.37 6 0.06 0.34 6 0.09






















































































340capillary fields, and five to seven draining postcapillary venules.
Video printouts were made during videography and initially marked
to indicate the exact localization for measurements of vessel diameter
and red blood cell (RBC)-velocity. Using a computer-assisted image
analysis system (CapImage; Zeintl Software; Heidelberg, Germany),
functional capillary density (FCD) was assessed as the length of
RBC-perfused capillaries per observation area (cm/cm2) [27]. Diame-
ters were measured in micrometers (mm) perpendicularly to the vessel
path. Centerline RBC-velocity was analyzed by computer-assistance
using the line-shift method (CapImage). Volumetric blood flow was
calculated from diameter (d) and RBC-velocity (v) by Q ¼ p * (d/2) 2
* v/1.6 (pl/s), where 1.6 represents the Baker-Wayland factor to cor-
rect for the parabolic velocity profile in microvessels with diameters
> 20 mm [28]. Rolling leukocytes were defined as cells moving with
a velocity less than two-fifth of the centerline velocity, and are given
as number of cells per minute passing a reference point within the mi-
crovessel. The number of permanent adherent leukocytes (defined as
cells that adhered to the venular vessel wall over a period of 30 s) was
evaluated as number of cells per square millimeter endothelial
surface (calculated from diameter and length of the vessel segment
studied, assuming cylindrical geometry) [26].T
E
D
PBlood flow [pl/s] 93.9 6 15.6 99.5 6 14.8 92.1 6 16.4Leukocyte-endothelialcell interaction
Rolling [cells/min] 1.52 6 0.51 1.33 6 0.4 1.26 6 0.26
Adherence [cells/mm2] 121 6 13 116 6 9 123 6 26
Values are mean6 SD. Note that there were no significant differ-

















The study comprised three different groups. Sham animals (n ¼ 6)
underwent chamber preparation without ESWA. One ESWA group
(n ¼ 6) received 500 pulses at 0.08 mJ/mm2, the other ESWA group
(n ¼ 6) received 1000 pulses. Sham-treated animals (n ¼ 6) received
0 pulses. Repetitive intravital microscopic observations were
performed at baseline (BL) before ESWA and at 1, 2, 6 h as well
as 1, 2, and 3 d after ESWA. Sham-treated animals were studied
at corresponding time points and served as controls. At the end of
the experiments, the animals were euthanized by injection of an
overdose of the anaesthetic. Five additional animals of each group



































Tissues were evaluated for caspase-3 (casp-3), PCNA, von Wille-
brand factor (vWF), and endothelial nitric oxide synthase (eNOS) by
immunohistochemistry. Tissue samples were obtained from the mid-
dle of the chamber tissue 1 d after ESWA. They were fixed in 4% para-
formaldehyde, washed in phosphate buffered saline (PBS), stored in
70% ethanol, and finally embedded in paraffin blocks. For analysis
of expression of casp-3, PCNA, vWF, and eNOS, 4 mm sections were
incubated with a primary rabbit anti-casp-3 antibody (1:500; Abcam),
a primary rabbit anti-PCNA antibody (1:500; Abcam), a primary rab-
bit anti-factor 8-(vWF) antibody (1:1000; Dako, A 0082), and a primary
rabbit anti-eNOS antibody (1:20; Assay Design, 905-386) over night at
RT. As secondary antibody the anti-rabbit EnVision (DakoCytoma-
tion EnVisionþSystem Labelled Polymer-HRP Anti-Rabbit K4003;
Zug, Switzerland) was used for 30 min at RT and AEC (Aminoethyl
Carbazole Substrate Kit; Zymed Laboratories, San Francisco, CA)
was applied as chromogen. Between each step, the slides were washed
with PBS (pH 7.4) and in each trial, positive and negative control
slides were included. Casp-3 and PCNA were examined by the aver-
age of positive cells counted in 10 randomly selected visual fields at
a magnification of320. Sebaceous glands and hair follicles were iden-
tified and excluded from the cell counts because of their consistently
high apoptosis rate. VWF was examined by the average of positive en-
dothelial cells counted in 10 randomly selected visual fields at a mag-
nification of 320. The intensity of the staining reactions of eNOS in
endothelial cells was evaluated by a Zeiss Axioplan 2 imaging system
(Carl Zeiss, Oberkochen, Germany) at a magnification of 3100 using
a semiquantitative score (graded as 0 ¼ no, 1 ¼ weak, 2 ¼ moderate,
and 3 ¼ strong staining).FLA 5.0 DTD  YJSRE10075_proofStatistical Analysis
All values are expressed as means 6 standard deviation (SD). For
comparison between individual time points, ANOVA for repeated
measures was performed, which was followed by the appropriate
post-hoc test, including the correction of the a-error according to Bon-
ferroni probabilities. ANOVA for comparison of multiple groups was
performed to compare treatment groups with sham, followed by Stu-
dent-Newman-Keuls test for appropriate post-hoc analysis (Sigma-
Stat; Jandel, San Rafael, CA). A P value < 0.05 was taken to
indicate statistically significant differences.RESULTS
Analysis of arteriolar and venular diameters, RBC-
velocities, and blood flows revealed comparable values
at BL in all groups studied (Table 1). ESWA did not sig-
nificantly affect diameters and flow conditions in arteri-
oles and venules during the entire phase of observation
(data not shown). Also, venular wall shear rates were
not affected by ESWA (data not shown).
Analysis of FCD as well as capillary diameter, RBC-
velocity, and blood flow revealed comparable values at
BL in all groups studied (Table 1). However, neither
500 nor 1000 pulses of ESWA resulted in significant
changes of capillary diameters, RBC-velocity, and blood
flow during the postinterventional period of observa-
tion (data not shown). Strikingly, ESWA provoked a sig-
nificant increase (P < 0.05) of FCD compared with BL
and sham-operated animals, which lasted during the
whole period of observation (Fig. 1). When animals



























































FIG. 1. Functional capillary densities [given in percent changes of
baseline (BL)] in the mouse dorsal skinfold chamber of sham-treated
animals (B), and after extracorporeal shock wave application
(ESWA) immediately after BL with 500 pulses ( )Q8 , or 1000 pulses
(C) at an energy flux rate of 0.08 mJ/mm2 and a frequency of 4 Hz.
Analyses were performed at BL as well as at 1, 2, 6 h, and 1, 2, and
3 d after ESWA. Data represent mean values6 SD (n ¼ 6 per group).
*P< 0.05 versus BL and sham-treated animals at corresponding time


















































































FIG. 2. Leukocyte rolling (A) and leukocyte firm adherence (B)
[given in percent changes of baseline (BL)] in the mouse dorsal skin-
fold chamber of sham-treated animals (B), and after extracorporeal
shock wave application (ESWA) immediately after BL with 500 pulses
( ) Q10, or 1000 pulses (C) at an energy flux rate of 0.08 mJ/mm2 and a fre-
quency of 4 Hz. Analyses were performed at BL as well as at 1, 2, 6 h,
and 1, 2, and 3 d after ESWA. Note that ESWA provokes a dose-depen-
dant transient inflammatory response. Data represent mean values6
SD (n ¼ 6 per group). *P < 0.05 versus BL and sham-treated animals
at corresponding time points; **P < 0.05 versus 500 pulses at corre-
sponding time point.











































































































































even more pronounced compared with 500 pulses only
(P < 0.05, not significant at 6 h, 2 and 3d).
Analysis of venular leukocyte rolling and adherence
revealed comparable values at BL in all groups studied
(Table 1). ESWA provoked an increase (P< 0.05) of leu-
kocyte rolling, which was most pronounced 24 h after
application of 1000 pulses (w3.5-fold) and then gradu-
ally decreased to values comparable to those observed
at BL (Fig. 2A). When animals were treated with 1000
pulses, increased leukocyte rolling was even more pro-
nounced compared with 500 pulses only (P < 0.05, not
significant at 1 h and 3 d). In line with this, leukocyte
adherence was increased (P < 0.05) maximally
w2-fold 24 h after application of 1000 pulses and then
gradually decreased to values comparable to those
observed at BL (Fig. 2B).
The numbers of interstitial casp-3 and PCNA positive
cells at d 1 following ESWA are demonstrated in Fig. 3.
ESWA enhanced casp-3 expressionw3.5-fold (P < 0.05
versus sham) when animals were treated with 500
pulses andw4.5-fold (P < 0.05 versus other groups) af-
ter 1000 pulses. PCNA expression was enhancedw9.5-
fold (P < 0.05 versus sham) when animals were treated
with 500 pulses and w14-fold (P < 0.05 versus other
groups) after 1000 pulses.
The number of vWF positive endothelial cells at d 1
following ESWA is demonstrated in Fig. 4A. Expression
of vWF was distinct in the endoluminal aspects of endo-
thelial cells in untreated animals. Five hundred pulses
increased the number of vWF positive endothelial cells
w14-fold (P < 0.05 versus sham), whereas 1000 pulses
led to a w11-fold increased cell count (P < 0.05 versus
sham).
Expression of eNOS was distinct in the endoluminal
aspects of endothelial cells in untreated animals.FLA 5.0 DTD  YJSRE10075_proof Following ESWA, however, the entire cytoplasm
showed a w3-fold increase in eNOS expression (P <
0.05 versus sham) with no significant difference
between 500 and 1000 pulses (Fig. 4B).
Representative photographs of immunohistochemi-
cally stained paraffin sections are shown in Fig. 5.DISCUSSION
Herein we report for the first time that ESWA to the
microcirculation of striated muscle is capable of
increasing capillary patency starting as early as 1 h af-
ter application. This effect is most likely conveyed by in-
creased availability of nitric oxide (NO) within the
stimulated endothelium, since eNOS has been found
to be up-regulated. ESWA also provoked a slight micro-
vascular inflammatory tissue response lasting as long




































FIG. 3. Averages of caspase-3 (casp-3) and proliferating cell nu-
clear antibody (PCNA) positive cells of 10 randomly selected visual
fields in the mouse dorsal skinfold chamber of sham-treated animals
(white bars) and 1 d after extracorporeal shock wave application
(ESWA) with 500 pulses (grey bars), or 1000 pulses (black bars) at
an energy flux rate of 0.08 mJ/mm2 and a frequency of 4 Hz. Note
dose-dependant accumulation of apoptotic cells after ESWA and stim-
ulation of angiogenesis-related PCNA. Data represent mean values6
SD (n ¼ 6 per group). *P < 0.05 versus sham-treated animals; **P <
0.05 versus 500 pulses.



















































































































indicates apoptotic effects, and increased production of
PCNA within the tissue confirms previous findings
suggesting that shock wave treatment may entail
proliferative effects.
The first description of the therapeutic use of high-
energy shock waves in 1980 revolutionized the
treatment of urinary calculi [29]. Since then, numerous
studies have demonstrated favorable biological
responses during fracture healing as well as for the
treatment of inflammatory soft tissue pathologies of
tendons and joints [1, 2, 3, 30–35]. However, the mecha-
nisms by which the target tissues respond to ESWA are
not understood. Davis et al. showed in a mouse model of
full-thickness burn that ESWT causes significant
anti-inflammatory effects associated with a decrease of






































FIG. 4. Averages of von Willebrand factor (vWF) positive endothelia
of endothelial nitric oxide synthase (eNOS) (B) in the mouse dorsal skinf
corporeal shock wave application (ESWA) with 500 pulses (grey bars), o
a frequency of 4 Hz. Note that ESWA enhanced vWF and eNOS expressio
6 per group). *P < 0.05 versus sham-treated animals; **P < 0.05 versus







leukocyte recruitment 1 h after the injury [36]. Inflam-
matory response in this study, however, was quantified
based on in vitro methods such as RT-PCR screening of
188 candidate genes and immunohistology of leukocyte
and macrophage infiltration. In contrast to this, our
study, which investigates the effects of ESWA on the
microcirculation for the first time in an in vivo setting,
clearly revealed, even if slight, a pro-inflammatory re-
sponse with a significant increase in rolling and sticking
leukocytes to the endothelial lining. This tissue reaction
started immediately after ESWA at an energy rate of
0.08 mJ/mm2 with 500 and 1000 pulses at a frequency
of 4 Hz and slowly declined over a time period of 3 d.
On the other hand, beneficial properties of ESWA
could be observed in parallel, namely the significant in-
crease in FCD of 20% after 1 h with a maximal increase
of 40% after 24 h in the 1000 pulse group. This effect was
also reproducible, however to a lesser extent, after the
application of 500 pulses, and was maintained for 3
d in both groups. The rapid increase in FCD most likely
was caused by the recruitment of capillaries. Capillary
recruitment, a well-known phenomenon, is observed
during hypoxia, exercise, or neural stimulation
[37–39]. Increased local production of endothelial-
derived NO hasbeenpresumed asa possible mechanism,
since blocking of NOS enzymes inhibited microvascular
recruitment [40]. In our study, eNOS was significantly
up-regulated 1 d after ESWA. The observation of in-
creased eNOS levels after ESWA is in line with findings
of other researchers [41–43]. In addition, we observed
a significantly increased expression of vWF within the
endothelial lining. VWF is a strong marker of endothe-
lial activation and is intensively expressed, for instance,
during acute coronary syndromes [44, 45]. Thus, it can
be hypothesized that the mechanical force applied
through ESWA activates the endothelium causing up-
































l cells (A) of 10 randomly selected visual fields and staining intensities
old chamber of sham-treated animals (white bars) and 1 d after extra-
r 1000 pulses (black bars) at an energy flux rate of 0.08 mJ/mm2 and
n in vascular endothelial cells. Data represent mean values6 SD (n¼
1000 pulses.











































FIG. 5. Immunohistologic demonstration (red staining) of caspase-3 (casp-3), proliferating cell nuclear antibody (PCNA), von Willebrand
factor (vWF), and endothelial nitric oxide synthase (eNOS) in cross sections of the mouse dorsal skinfold 1 d after extracorporeal shock wave
application (ESWA) with 500 pulses or 1000 pulses at an energy flux rate of 0.08 mJ/mm2 and a frequency of 4 Hz compared with normal ex-
pression in sham-operated animals. Note the strong expression of PCNA in the interstitium (arrowheads) and vWF as well as eNOS in endo-
thelial cells (arrows) following ESWA. Note also a marked accumulation of casp-3 positive apoptotic cells in the tissue (stars) after 500 and 1000
pulses. (Scale bar ¼ 100 mm).





































































































































CNext to the acute effects on the vascular systemcaused by ESWA, angiogenesis has been presumed to
play a role in long-term effects. De Sanctis et al. treated
patients suffering from advanced ischemic limb disease
with low dose shock waves with energy levels ranging
from 0.03 to 0.5 mJ/mm2, and found a significant in-
crease in local perfusion as measured by laser Doppler
flux measurements [14]. These measurements coin-
cided with the clinical improvement of the patient’s
pain-free walking distance. The effects of shock waves
on distal ischemic skin flap necrosis were examined in
rats using different skin flap models [13, 19–21]. All
studies showed a significant increase in mean percent-
age of the flap survival area after ESWA and can be
seen as an indicator of improved local perfusion.
VEGF is a well known mitogen, which not only acts as
a vasodilator and increases endothelial permeabilityFLA 5.0 DTD  YJSRE10075_proof but also plays a significant role during angiogenesis
[46]. Gutersohn et al. exposed HUVECs to low dose
shock waves [22]. Quantification of VEGF m-RNA 36
h after treatment revealed a significant up-regulation
of the protein. Wang et al. used the Achilles tendon of
dogs to investigate the proposed induction of neovascu-
larisation after ESWA histologically. Indeed, they
found a considerable increase of the number of newly
formed vessels and muscularized vessels at 4 and 8
wk after treatment [47]. Meirer et al. employed the
rat epigastric skin flap model not only to compare the ef-
fectiveness of shock wave treatment to an untreated
control group, but also to the intravenous treatment
with adenovirus-mediated VEGF or TGF-b [48, 49].
Neither gene therapy with TGF-b nor VEGF were as ef-
fective in increasing the percentage of flap survival
compared with ESWA. Kuo et al. observed an increase4 January 2010  12:32 pm  ce











































































































































in VEGF and PCNA expression in shock wave treated
random flaps in rats [13]. In our study, we found an
up-regulation of PCNA, which is an early marker for
cell proliferation. However, no microvascular angio-
genic signs, such as the formation of buds or sprouts
from the microvasculature, were observed in the first
3 d after ESWA. Elsewhere, when applying models of
incisional wound healing, these angiogenic changes
originating from capillaries and venules are clearly vis-
ible as early at 2 d after the incision in the dorsal skin-
fold chamber. Thus, it can be deduced that a potential
angioproliferative response to ESWT may be triggered
as early as 1 h after shock wave application, as indi-
cated by the substantially increased level of PCNA.
However, neither vasculogenesis nor angiogenesis
were initialized within the first 3 d. Assuming normoxia
in our model and taking into consideration that hypoxia
is the most important trigger to induce angiogenesis in
noncancerous tissue, further studies are necessary to
investigate whether ESWA is capable of rapidly form-
ing new vessels in critically perfused tissues to counter-
act hypoxic tissue damage.
Stojadinovic et al. described an increased expression
of pro-angiogenic genes applying cDNA super arrays af-
ter full-thickness skin grafting starting at 6 h after
ESWA resulting in an increased vessel density in im-
munohistological sections [51]. Again, merely in vitro
methods were applied lacking the possibility to assess
the formation and patency of newly formed vessels in
vivo.
The increase in cleaved casp-3 expression 1 h after
ESWA in our study implies a proapoptotic effect [52].
In line with our investigations, beneficial structural
changes in the rat penis after ESWA treatment of Peyr-
onie’s disease were associated with a higher apoptotic
index [53]. However, a study investigating the influ-
ence of ESWA during urethral stone therapy on ovarian
tissue, apoptosis did not reveal an increased apoptotic
cell death [54]. Findings in a segmental bone defect
model indicated the increase in TGF-b and also
VEGF-A played a chemotactic and mitogenic role in
the recruitment and differentiation of mesenchymal
stem cells [7]. In a further study, the authors could
also show a significant induction of mitogen-activated
protein kinase activity regulators in cell growth, differ-
entiation, and apoptosis, which lasted up to 42 d after
ESWA [55].
It can be concluded that ESWA leads to an immedi-
ate, slight inflammatory tissue response in vivo, which
is paralleled by a pronounced and long-lasting, most
probably NO-related capillary recruitment starting as
early as 1 h after ESWA. The application of this
mechanical energy most likely activates the vascular
endothelium by the up-regulation of resident enzymes
and factors such as eNOS and vWF. Even if prolifera-FLA 5.0 DTD  YJSRE10075_prooftion indicator PCNA was found to be up-regulated,
angiogenesis phenomenons within the microvascula-
ture were not observed during the first 3 d. The findings
of the herein presented study warrant further research
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